Abstract
We report a novel piece-wise isothermal nucleic acid test (PINAT) for diagnosing pathogen-associated RNA that embeds an exclusive DNA-mediated specific probing reaction with the backbone of an isothermal reverse-transcription cum amplification protocol as a unified single-step procedure. This single step sample-to-result test method has been seamlessly integrated in an inexpensive, scalable, pre-programmable and portable instrument, resulting in a generic platform technology for detecting nucleic acid from a wide variety of pathogens. The test exhibited high sensitivity and specificity of detection when assessed using 200 double-blind patient samples for detecting SARS-CoV-2 infection conducted by the Indian Council of Medical Research (ICMR), reporting a positive and negative percent agreement of 94.6% and 98% respectively. We also established its efficacy in detecting influenza-A infection, performing the diagnosis at the point of collection with uncompromised detection rigor. The envisaged trade-off between advanced laboratory-based procedures with the elegance of common rapid tests renders the innovation to be ideal for deployment in resource-limited settings towards catering the needs of the underserved.
Competing Interest Statement
Part of this work has been transferred as technology to commercial entities. Parts of the work are protected by the following filed patents: 1.A Point of Care (POC) Device for Facilitating Nucleic Acid Based Testing and Method Thereof (PCT/ IN2021/050218; US Patent Application Number 17201968) 2.A Method for POC-Based Detection of Pathogenic Infection via Nucleic Acid Based Testing (US Patent Application Number 17202903) 3.Detection of Viral RNA: A Portable Device and Method Thereof (Indian Patent Application Number: 202031031597), owned by the Indian Institute of Technology Kharagpur.
Funding Statement
All authors acknowledge the Indian Institute of Technology Kharagpur and the Indian Council for Medical Research (ICMR) for facilitating different components of the work. SC acknowledges DSIR, Government of India for financial support through CRTDH Project on Affordable Healthcare and DST (SERB), Government of India, for Sir J. C. Bose National Fellowship. AM acknowledges DBT-Ramalingaswami Re-entry Fellowship and DST-SERB Early Career Research Award. SB, NK and AD acknowledge Council of Scientific and Industrial Research for their fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol for all patient samples related work has been reviewed and approved by the Ethical Committee of the institution (IIT Kharagpur).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Detailed data of the patient sample validation work is available in the Supplementary file.
